(Q46690494)

24 December 2017

title

Randomized dose-controlled study of topiramate as first-line therapy in epilepsy (English)

1 reference

24 December 2017

author name string

S Arroyo

1

1 reference

24 December 2017

W E Dodson

2

1 reference

24 December 2017

M D Privitera

3

1 reference

24 December 2017

T A Glauser

4

1 reference

24 December 2017

D K Naritoku

5

1 reference

24 December 2017

D J Dlugos

6

1 reference

24 December 2017

S Wang

7

1 reference

24 December 2017

S K Schwabe

8

1 reference

24 December 2017

R E Twyman

9

1 reference

24 December 2017

EPMN-106/INT-28 Investigators

10

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

24 December 2017

Acta Neurologica Scandinavica

published in

1 reference

24 December 2017

volume

112

1 reference

24 December 2017

page(s)

214-222

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00485.X

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00485.X

A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00485.X

Low-dose topiramate in adults with treatment-resistant partial-onset seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00485.X

A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00485.X

Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00485.X

Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00485.X

Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00485.X

Early identification of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00485.X

Early development of intractable epilepsy in children: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00485.X

Long-term prognosis of seizures with onset in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00485.X

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00485.X

Effectiveness of first antiepileptic drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00485.X

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00485.X

10.1111/J.1600-0404.2005.00485.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

16146489

1 reference

24 December 2017